| Erlotinib in previously treated non–small-cell lung cancer FA Shepherd, J Rodrigues Pereira, T Ciuleanu, EH Tan, V Hirsh, ... New England journal of medicine 353 (2), 123-132, 2005 | 7260 | 2005 |
| Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer TS Mok, YL Wu, MJ Ahn, MC Garassino, HR Kim, SS Ramalingam, ... New England Journal of Medicine 376 (7), 629-640, 2017 | 3667 | 2017 |
| Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer RJ Ginsberg, LV Rubinstein, Lung Cancer Study Group The Annals of thoracic surgery 60 (3), 615-623, 1995 | 3504 | 1995 |
| Randomized phase III trial of pemetrexed versus docetaxel in patients with non–small-cell lung cancer previously treated with chemotherapy N Hanna, FA Shepherd, FV Fossella, JR Pereira, F De Marinis, ... Journal of clinical oncology 22 (9), 1589-1597, 2004 | 3469 | 2004 |
| Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group JP Pignon, H Tribodet, GV Scagliotti, JY Douillard, FA Shepherd, ... Journal of clinical oncology 26 (21), 3552-3559, 2008 | 3063 | 2008 |
| Prospective randomized trial of docetaxel versus best supportive care in patients with non–small-cell lung cancer previously treated with platinum-based chemotherapy FA Shepherd, J Dancey, R Ramlau, K Mattson, R Gralla, M O’Rourke, ... Journal of Clinical Oncology 18 (10), 2095-2103, 2000 | 2924 | 2000 |
| Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer T Winton, R Livingston, D Johnson, J Rigas, M Johnston, C Butts, ... New England Journal of Medicine 352 (25), 2589-2597, 2005 | 2362 | 2005 |
| Erlotinib in lung cancer—molecular and clinical predictors of outcome MS Tsao, A Sakurada, JC Cutz, CQ Zhu, S Kamel-Reid, J Squire, ... New England Journal of Medicine 353 (2), 133-144, 2005 | 2324 | 2005 |
| Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial ES Kim, V Hirsh, T Mok, MA Socinski, R Gervais, YL Wu, LY Li, ... The Lancet 372 (9652), 1809-1818, 2008 | 1781 | 2008 |
| Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial KS Albain, RS Swann, VW Rusch, AT Turrisi, FA Shepherd, C Smith, ... The Lancet 374 (9687), 379-386, 2009 | 1752 | 2009 |
| Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer YL Wu, M Tsuboi, J He, T John, C Grohe, M Majem, JW Goldman, ... New England Journal of Medicine 383 (18), 1711-1723, 2020 | 1669 | 2020 |
| Characterizing the cancer genome in lung adenocarcinoma BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ... Nature 450 (7171), 893-898, 2007 | 1296 | 2007 |
| Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer J Von Pawel, JH Schiller, FA Shepherd, SZ Fields, JP Kleisbauer, ... Journal of Clinical Oncology 17 (2), 658-658, 1999 | 1175 | 1999 |
| Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Nature medicine 14 (8), 822-827, 2008 | 1157 | 2008 |
| Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study MD Hellmann, NA Rizvi, JW Goldman, SN Gettinger, H Borghaei, ... The lancet oncology 18 (1), 31-41, 2017 | 1066 | 2017 |
| EGFR mutations and lung cancer G da Cunha Santos, FA Shepherd, MS Tsao Annual Review of Pathology: Mechanisms of Disease 6 (1), 49-69, 2011 | 1015 | 2011 |
| The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies G Scagliotti, N Hanna, F Fossella, K Sugarman, J Blatter, P Peterson, ... The oncologist 14 (3), 253-263, 2009 | 920 | 2009 |
| Non-small-cell lung cancer P Goldstraw, D Ball, JR Jett, T Le Chevalier, E Lim, AG Nicholson, ... The Lancet 378 (9804), 1727-1740, 2011 | 895 | 2011 |
| Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 CQ Zhu, G da Cunha Santos, K Ding, A Sakurada, JC Cutz, N Liu, ... Journal of clinical oncology 26 (26), 4268-4275, 2008 | 879 | 2008 |
| Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data NSCLC Meta-analyses Collaborative Group The Lancet 375 (9722), 1267-1277, 2010 | 744 | 2010 |
